Adherence to treatment Quality of life Adverse events (please specify and use multiple rows) Section 6: Clinical trial quality Method of randomisation Method of allocation concealment Method of masking and who was masked Number of patients lost to follow up (the overall number and number by treatment group, give reasons for loss to follow up) Section 7: Additional comments Additional comments (e.g., power calculation, important changes to protocol, type of analysis) Further information that could be requested from authors Abbreviations used in table: CI, confidence interval; n, number of patients with the outcome; N, number of patients assessed; QoL, quality of life; RCT, randomised controlled trial; SD, standard deviation; SE, standard error. Risk of bias assessment for individual trials Risk of bias Low Unclear High Support for risk risk risk judgement Trial design Random sequence generation Allocation concealment
Adherence to treatment Quality of life Adverse events (please specify and use multiple rows) Section 6: Clinical trial quality Method of randomisation Method of allocation concealment Method of masking and who was masked Number of patients lost to follow up (the overall number and number by treatment group, give reasons for loss to follow up) Section 7: Additional comments Additional comments (e.g., power calculation, important changes to protocol, type of analysis) Further information that could be requested from authors Abbreviations used in table: CI, confidence interval; n, number of patients with the outcome; N, number of patients assessed; QoL, quality of life; RCT, randomised controlled trial; SD, standard deviation; SE, standard error. Risk of bias assessment for individual trials Risk of bias Low risk Unclear risk High risk Support for judgement Trial design Random sequence generation Allocation concealment